You spoke, they listened! 📣
55,000 of you backed our #NoTimeToWaste campaign and now you've helped to secure action from @NHSEngland which could mean more women attending their breast screening, and more lives saved.
https://t.co/CA1xEOYeKa
Next Tuesday, the Tobacco and Vapes Bill will have its Second Reading in Parliament.
You can make a difference: email your MP using our quick and easy form, and ask them to back the Bill and support legislation to raise the age of sale for tobacco.
It's vital that urgent progress is now made, and a solution is found to make #Enhertu available across the UK.
Join us to call on @ASTRAZENECAUK, @daiichisankyouk , @NICEComms and @NHSEngland to seize this opportunity and get this drug to the women who so desperately need it.
More than a thousand patients with advanced breast cancer are being denied a drug that can keep them alive for longer.
“It's deeply unjust that patients are caught in a stand-off between NICE and the pharma companies” - our chief exec @clairerowney
https://t.co/cTCMh0ngvX
"To have it on the shelf and you just can't reach - it's heart breaking." - @BrineMP sums up the frustration of knowing #Enhertu exists, but can't be accessed by the women who could benefit from it.
“We are not just numbers. We are people with lives that we are so desperate to continue living” – Hannah
@LauraPriceWrite talks to Hannah Gardner about the life-extending drug Enhertu, which has just been rejected for use on the NHS in England.
https://t.co/RGqzVCxKw1
Over 25,000 people have already backed our call for a national breast screening awareness campaign! Thanks for the incredible support. If you haven't already, please add your name today👇 #NoTimeToWaste
https://t.co/gNwgUN0DaZ
I'm backing @BreastCancerNow's call for a national breast screening awareness campaign. More women screened means more lives saved from breast cancer. Will you join me? #NoTimeToWaste https://t.co/xEbz78GT7V
#Enhertu for HER2-low breast cancer is a drug that offers women like Tracy the life-changing hope of more time to live. But they're facing an agonising wait to see if they can access it on the NHS.
@NHSEngland and @DaiichiSankyoUK must urgently agree a deal to make it available.
"Give us hope for the future.”
We’re sharing an open letter from 6 women with HER2-low incurable secondary breast cancer: @NICEComms, @DaiichiSankyoUK and @NHSEngland work together so trastuzumab deruxtecan (Enhertu) is available on the NHS in England.
https://t.co/tNREVN4jx2
@RoseONei11 Yes they really are and I think it's an issue that can be, and has been, overlooked. It's something I just didn't think about or realise until I was a bit older and took my nieces and then my own kids - how important it is to have access to parks and playgrounds.
The breast screening programme saves women’s lives from breast cancer. It’s been instrumental to breast cancer survival rates doubling in the last 40 years.
But it’s at breaking point.
Join me and over 60 cancer charities coming together as #OneCancerVoice asking the Prime Minister to address the cancer emergency in England. Sign the petition (hosted by CRUK): https://t.co/yzWRAmibpF